-
1
-
-
34447508481
-
Environmental risk factors for multiple sclerosis. Part II: non-infectious factors
-
Ascherio A. Munger K.L. (2007) Environmental risk factors for multiple sclerosis. Part II: non-infectious factors. Ann Neurol 61: 504–513.
-
(2007)
Ann Neurol
, vol.61
, pp. 504-513
-
-
Ascherio, A.1
Munger, K.L.2
-
4
-
-
55249098110
-
Evaluation and correction of low vitamin D status
-
Binkley N. Krueger D. (2008) Evaluation and correction of low vitamin D status. Curr Osteoporos Rep 6: 95-99.
-
(2008)
Curr Osteoporos Rep
, vol.6
, pp. 95-99
-
-
Binkley, N.1
Krueger, D.2
-
6
-
-
63849282684
-
Prevention of non-vertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials
-
Bischoff-Ferrari H.A. Willett W.C. Wong J.B. Stuck A.E. Staehelin B. Orav E.J. et al. (2009) Prevention of non-vertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169: 551–561.
-
(2009)
Arch Intern Med
, vol.169
, pp. 551-561
-
-
Bischoff-Ferrari, H.A.1
Willett, W.C.2
Wong, J.B.3
Stuck, A.E.4
Staehelin, B.5
Orav, E.J.6
-
7
-
-
77953328331
-
A phase I / II dose escalation trial of vitamin D 3 and calcium in multiple sclerosis
-
Burton J.M. Kimball S. Vieth R. Bar-Or A. Dosch H.M. Cheug R. et al. (2010) A phase I / II dose escalation trial of vitamin D 3 and calcium in multiple sclerosis. Neurology 74: 1852–1859.
-
(2010)
Neurology
, vol.74
, pp. 1852-1859
-
-
Burton, J.M.1
Kimball, S.2
Vieth, R.3
Bar-Or, A.4
Dosch, H.M.5
Cheug, R.6
-
9
-
-
77954546834
-
Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs
-
Cavalier E. Rozet E. Gadisseur R. Carlisi A. Monge M. Chapelle J.P. et al. (2010) Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int 21: 1047–1051.
-
(2010)
Osteoporos Int
, vol.21
, pp. 1047-1051
-
-
Cavalier, E.1
Rozet, E.2
Gadisseur, R.3
Carlisi, A.4
Monge, M.5
Chapelle, J.P.6
-
10
-
-
66549129834
-
Immunomodulatory aspects of vitamin D in multiple sclerosis
-
Correale J. Ysrraelit M.C. Gaitan M.I. (2009) Immunomodulatory aspects of vitamin D in multiple sclerosis. Brain 132: 1146–1160.
-
(2009)
Brain
, vol.132
, pp. 1146-1160
-
-
Correale, J.1
Ysrraelit, M.C.2
Gaitan, M.I.3
-
11
-
-
78049509828
-
Gender differences in 1,25 dihydroxyvitamin D 3 immunomodulatory effects in multiple sclerosis patients and healthy subjects
-
Correale J. Ysrraelit M.C. Gaitan M.I. (2010) Gender differences in 1,25 dihydroxyvitamin D 3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185: 4948-4958.
-
(2010)
J Immunol
, vol.185
, pp. 4948-4958
-
-
Correale, J.1
Ysrraelit, M.C.2
Gaitan, M.I.3
-
12
-
-
84887844827
-
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized trial
-
Dorr J. Ohlraun S. Skarabis H. Paul F. (2012) Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized trial. Trials 13: 15.
-
(2012)
Trials
, vol.13
, pp. 15
-
-
Dorr, J.1
Ohlraun, S.2
Skarabis, H.3
Paul, F.4
-
13
-
-
38949107656
-
Environmental factors and multiple sclerosis
-
Ebers G.C. (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268–277.
-
(2008)
Lancet Neurol
, vol.7
, pp. 268-277
-
-
Ebers, G.C.1
-
14
-
-
58149085571
-
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis
-
Gajofatto A. Baccheti P. Grimes B. High A. Waubant E. (2009) Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. Mult Scler 15: 50–58.
-
(2009)
Mult Scler
, vol.15
, pp. 50-58
-
-
Gajofatto, A.1
Baccheti, P.2
Grimes, B.3
High, A.4
Waubant, E.5
-
15
-
-
0022969013
-
Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D
-
Goldberg P. Fleming M.C. Picard E.H. (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21: 193–200.
-
(1986)
Med Hypotheses
, vol.21
, pp. 193-200
-
-
Goldberg, P.1
Fleming, M.C.2
Picard, E.H.3
-
16
-
-
21344463548
-
Benefits and requirements of vitamin D for optimal health: a review
-
Grant W.B. Holick M.F. (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10: 94–111.
-
(2005)
Altern Med Rev
, vol.10
, pp. 94-111
-
-
Grant, W.B.1
Holick, M.F.2
-
17
-
-
20044388168
-
Twenty-four-month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®)
-
Haas J. Firzlaff M. (2005) Twenty-four-month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®). Eur J Neurol 12: 425–431.
-
(2005)
Eur J Neurol
, vol.12
, pp. 425-431
-
-
Haas, J.1
Firzlaff, M.2
-
18
-
-
57049086978
-
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis
-
Hagenau T. Vest R. Gissel T.N. Poulsen C.S. Erlandsem M. Mosekilde L. et al. (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20: 133–140.
-
(2009)
Osteoporos Int
, vol.20
, pp. 133-140
-
-
Hagenau, T.1
Vest, R.2
Gissel, T.N.3
Poulsen, C.S.4
Erlandsem, M.5
Mosekilde, L.6
-
19
-
-
77249132585
-
Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations
-
Hall L.M. Kimlin M.G. Aronov P.A. Hammock B.D. Slusser J.R. Woodhouse L.R. (2010) Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140: 542–550.
-
(2010)
J Nutr
, vol.140
, pp. 542-550
-
-
Hall, L.M.1
Kimlin, M.G.2
Aronov, P.A.3
Hammock, B.D.4
Slusser, J.R.5
Woodhouse, L.R.6
-
20
-
-
78650174045
-
Assessment of evidence for a protective role of vitamin D in multiple sclerosis
-
Hanwell H.E.C. Banwell B. (2011) Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta 1812: 202–212.
-
(2011)
Biochim Biophys Acta
, vol.1812
, pp. 202-212
-
-
Hanwell, H.E.C.1
Banwell, B.2
-
21
-
-
0033807020
-
Vitamin D: how much do we need and how much is too much?
-
Heaney R. (2000) Vitamin D: how much do we need and how much is too much? Osteoporos Int 11: 553–555.
-
(2000)
Osteoporos Int
, vol.11
, pp. 553-555
-
-
Heaney, R.1
-
22
-
-
0037215304
-
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
-
Heaney R.P. Davies K.M. Chen T.C. Holick M.F. Bager-Lux J. (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204–210.
-
(2003)
Am J Clin Nutr
, vol.77
, pp. 204-210
-
-
Heaney, R.P.1
Davies, K.M.2
Chen, T.C.3
Holick, M.F.4
Bager-Lux, J.5
-
23
-
-
79951832240
-
Why the IOM recommendations for vitamin D are deficient
-
Heaney R.P. Holick M.F. (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Min Res 26: 455–457.
-
(2011)
J Bone Min Res
, vol.26
, pp. 455-457
-
-
Heaney, R.P.1
Holick, M.F.2
-
25
-
-
16544381338
-
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
-
Holick M.F. (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(Suppl.): 1678S–1688S.
-
(2004)
Am J Clin Nutr
, vol.80
, pp. 1678S-1688S
-
-
Holick, M.F.1
-
26
-
-
34447514029
-
Vitamin D deficiency
-
Holick M.F. (2007) Vitamin D deficiency. N Engl J Med 357: 266–281.
-
(2007)
N Engl J Med
, vol.357
, pp. 266-281
-
-
Holick, M.F.1
-
27
-
-
78650876692
-
Evolutionary, physiological and health perspectives
-
Holick M.F. (2011) Evolutionary, physiological and health perspectives. Curr Drug Targets 12: 4-18.
-
(2011)
Curr Drug Targets
, vol.12
, pp. 4-18
-
-
Holick, M.F.1
-
28
-
-
13244264697
-
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D
-
Hollis B.W. (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135: 317–322.
-
(2005)
J Nutr
, vol.135
, pp. 317-322
-
-
Hollis, B.W.1
-
29
-
-
40549104752
-
Pharmacokinetics of a single, large dose of cholecalciferol
-
Ilahi M. Armas L.A.G. Heaney R.P. (2008) Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 87: 688–691.
-
(2008)
Am J Clin Nutr
, vol.87
, pp. 688-691
-
-
Ilahi, M.1
Armas, L.A.G.2
Heaney, R.P.3
-
30
-
-
51649125765
-
Comparison of daily, weekly, and monthly vitamin D 3 in ethanol dosing protocols for two months in elderly hip fracture patients
-
Ish-Shalom S. Segal E. Salganik T. Raz B. Bromberg I.L. Vieth R. (2009) Comparison of daily, weekly, and monthly vitamin D 3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93: 3430–3435.
-
(2009)
J Clin Endocrinol Metab
, vol.93
, pp. 3430-3435
-
-
Ish-Shalom, S.1
Segal, E.2
Salganik, T.3
Raz, B.4
Bromberg, I.L.5
Vieth, R.6
-
31
-
-
84863600623
-
Effect of vitamin D 3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
-
Epub ahead of print
-
Kampman M.T. Steffensen L.H. Mellgren S.I. Jørgensen L. (2012) Effect of vitamin D 3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler [Epub ahead of print].
-
(2012)
Mult Scler
-
-
Kampman, M.T.1
Steffensen, L.H.2
Mellgren, S.I.3
Jørgensen, L.4
-
32
-
-
84863586189
-
Course of relapsing-remitting multiple sclerosis before, during and after natalizumab
-
Kaufman M.D. Lee R. Norton H. (2011) Course of relapsing-remitting multiple sclerosis before, during and after natalizumab. Mult Scler 7: 90–94.
-
(2011)
Mult Scler
, vol.7
, pp. 90-94
-
-
Kaufman, M.D.1
Lee, R.2
Norton, H.3
-
33
-
-
79953324326
-
Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and in healthy controls
-
Lysandropoulos A.P. Jaquiéry E. Jilek S. Pantealo G. Schluep M. Du Pasquier R.A. (2011) Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and in healthy controls. J Neuroimmunol 233: 240–244.
-
(2011)
J Neuroimmunol
, vol.233
, pp. 240-244
-
-
Lysandropoulos, A.P.1
Jaquiéry, E.2
Jilek, S.3
Pantealo, G.4
Schluep, M.5
Du Pasquier, R.A.6
-
34
-
-
0037223587
-
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation
-
Mahon B.D. Gordon S.A. Cruz J. Cosman F. Cantorna M.T. (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134: 128–132.
-
(2003)
J Neuroimmunol
, vol.134
, pp. 128-132
-
-
Mahon, B.D.1
Gordon, S.A.2
Cruz, J.3
Cosman, F.4
Cantorna, M.T.5
-
35
-
-
0034955141
-
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis
-
McDonald W.I. Compston A. Edan G. Goodkin D. Hartung H.P. Lublin F.D. et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121–7.
-
(2001)
Ann Neurol
, vol.50
, pp. 121-127
-
-
McDonald, W.I.1
Compston, A.2
Edan, G.3
Goodkin, D.4
Hartung, H.P.5
Lublin, F.D.6
-
37
-
-
82555176755
-
Prevention and treatment of MS: studying the effects of vitamin D
-
Munger K.L. Ascherio A. (2011) Prevention and treatment of MS: studying the effects of vitamin D. Mult Scler 17: 1405–1411.
-
(2011)
Mult Scler
, vol.17
, pp. 1405-1411
-
-
Munger, K.L.1
Ascherio, A.2
-
39
-
-
69549114460
-
Clinical implications of a possible role of vitamin D in multiple sclerosis
-
Pierrot-Deseilligny C. (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256: 1468–1479.
-
(2009)
J Neurol
, vol.256
, pp. 1468-1479
-
-
Pierrot-Deseilligny, C.1
-
40
-
-
77954353114
-
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
-
Pierrot-Deseilligny C. Souberbielle J.C. (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 133: 1869–1888.
-
(2010)
Brain
, vol.133
, pp. 1869-1888
-
-
Pierrot-Deseilligny, C.1
Souberbielle, J.C.2
-
41
-
-
79958827927
-
Widespread vitamin D insufficiency: a new challenge for primary prevention with particular reference to multiple sclerosis
-
Pierrot-Deseilligny C. Souberbielle J.C. (2011) Widespread vitamin D insufficiency: a new challenge for primary prevention with particular reference to multiple sclerosis. Presse Médicale 40: 349–356.
-
(2011)
Presse Médicale
, vol.40
, pp. 349-356
-
-
Pierrot-Deseilligny, C.1
Souberbielle, J.C.2
-
42
-
-
33644584352
-
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
-
Polman C.H. O'Connor P.W. Havrdova E. Hutchinson M. Kappos L. Miller D.H. et al. (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. New Engl J Med 354: 899–910.
-
(2006)
New Engl J Med
, vol.354
, pp. 899-910
-
-
Polman, C.H.1
O'Connor, P.W.2
Havrdova, E.3
Hutchinson, M.4
Kappos, L.5
Miller, D.H.6
-
45
-
-
78650886291
-
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know
-
Ross A.C. Manson E.J. Abrams S.A. Aloia J.F. Brannon P.M. Steven K. et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53–58.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 53-58
-
-
Ross, A.C.1
Manson, E.J.2
Abrams, S.A.3
Aloia, J.F.4
Brannon, P.M.5
Steven, K.6
-
46
-
-
68049101203
-
Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis
-
Royal W. III Mia Y. Li H. Nauton K. (2009) Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 213: 135–141.
-
(2009)
J Neuroimmunol
, vol.213
, pp. 135-141
-
-
Royal, W.1
Mia, Y.2
Li, H.3
Nauton, K.4
-
47
-
-
77953808199
-
Addressing vitamin D deficiency in Canada: a public health innovation whose time has come
-
Schwalfenberg G.K. Genuis S.J. Hiltz M.N. (2010) Addressing vitamin D deficiency in Canada: a public health innovation whose time has come. Public Health 124: 350–359.
-
(2010)
Public Health
, vol.124
, pp. 350-359
-
-
Schwalfenberg, G.K.1
Genuis, S.J.2
Hiltz, M.N.3
-
50
-
-
81255152070
-
Efficacy of vitamin D. (3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta 1-a: a phase II, multicenter, double-blind, randomized, placebo-controlled trial
-
Smolders J. Hupperts R. Barkhof R. Grimaldi L.M. Holmoy T. Killestein J. et al. (2011 a) Efficacy of vitamin D (3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta 1-a: a phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci 311: 44–49.
-
(2011)
J Neurol Sci
, vol.311
, pp. 44-49
-
-
Smolders, J.1
Hupperts, R.2
Barkhof, R.3
Grimaldi, L.M.4
Holmoy, T.5
Killestein, J.6
-
51
-
-
84863583814
-
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
-
Smolders J. Menheere P. Kessels A. Damoiseaux J. Hupperts R. (2008 b) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14: 1–5.
-
(2008)
Mult Scler
, vol.14
, pp. 1-5
-
-
Smolders, J.1
Menheere, P.2
Kessels, A.3
Damoiseaux, J.4
Hupperts, R.5
-
52
-
-
81255135921
-
Vitamin D in the healthy and inflamed central nervous system: access and function
-
Smolders J. Moen S.M. Damoiseaux J. Huitinga I. Holmoy T. (2011 b) Vitamin D in the healthy and inflamed central nervous system: access and function. J Neurol Sci 311: 37–43.
-
(2011)
J Neurol Sci
, vol.311
, pp. 37-43
-
-
Smolders, J.1
Moen, S.M.2
Damoiseaux, J.3
Huitinga, I.4
Holmoy, T.5
-
53
-
-
78650790685
-
Safety and T cell modulating effects of high dose vitamin D 3 supplementation in multiple sclerosis
-
Smolders J. Peelen E. Thewissen M. Cohen Tervaet J.W. Menheere P. et al. (2010) Safety and T cell modulating effects of high dose vitamin D 3 supplementation in multiple sclerosis. PloS ONE 5 (12): e15235.
-
(2010)
PloS ONE
, vol.5
, Issue.12
, pp. e15235
-
-
Smolders, J.1
Peelen, E.2
Thewissen, M.3
Cohen Tervaet, J.W.4
Menheere, P.5
-
54
-
-
68949140898
-
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis
-
Smolders J. Thewissen M. Peelen E. Menheere P. Tervaert J.W. Damoiseaux J. et al. (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PloS ONE 4: e6635.
-
(2009)
PloS ONE
, vol.4
, pp. e6635
-
-
Smolders, J.1
Thewissen, M.2
Peelen, E.3
Menheere, P.4
Tervaert, J.W.5
Damoiseaux, J.6
-
55
-
-
84859612741
-
A randomised, double blind, placebo controlled trial with vitamin D 3 as an add-on treatment to interferon β-1b in patients with multiple sclerosis
-
Soilu-Hänninen M. Aivo J. Lindström B.M. Elovaara I. Sumelhati M.L. Färkkilä M. et al. (2012) A randomised, double blind, placebo controlled trial with vitamin D 3 as an add-on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 83: 565–571.
-
(2012)
J Neurol Neurosurg Psychiatry
, vol.83
, pp. 565-571
-
-
Soilu-Hänninen, M.1
Aivo, J.2
Lindström, B.M.3
Elovaara, I.4
Sumelhati, M.L.5
Färkkilä, M.6
-
56
-
-
77956182419
-
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice
-
Souberbielle J.C. Body J.J. Lappe J.M. Plebani M. Shoenfeld Y. Wang T.J. et al. (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9: 709–715.
-
(2010)
Autoimmun Rev
, vol.9
, pp. 709-715
-
-
Souberbielle, J.C.1
Body, J.J.2
Lappe, J.M.3
Plebani, M.4
Shoenfeld, Y.5
Wang, T.J.6
-
57
-
-
34249079725
-
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
-
van der Mei I.A. Ponsonby A.L. Dwyer T. Blizzard L. Taylor B.V. Kilpatrick T. et al. (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254: 581–590.
-
(2007)
J Neurol
, vol.254
, pp. 581-590
-
-
van der Mei, I.A.1
Ponsonby, A.L.2
Dwyer, T.3
Blizzard, L.4
Taylor, B.V.5
Kilpatrick, T.6
-
59
-
-
33744933930
-
What is the optimal vitamin D status for health?
-
Vieth R. (2006) What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92: 26–32.
-
(2006)
Prog Biophys Mol Biol
, vol.92
, pp. 26-32
-
-
Vieth, R.1
-
61
-
-
77955052903
-
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
-
Wang T.J. Zhang F. Richards B. Kestenbaum B. van Meurs J.B. Berry D. et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180–188.
-
(2010)
Lancet
, vol.376
, pp. 180-188
-
-
Wang, T.J.1
Zhang, F.2
Richards, B.3
Kestenbaum, B.4
van Meurs, J.B.5
Berry, D.6
-
63
-
-
42249085423
-
Blood biomarkers on vitamin D status
-
Zerwekh J.E. (2008) Blood biomarkers on vitamin D status. Am J Clin Nutr 87: 1087S–1091S.
-
(2008)
Am J Clin Nutr
, vol.87
, pp. 1087S-1091S
-
-
Zerwekh, J.E.1
|